Utilities Registry

Filter results using search terms, or by selecting one or more valuation, condition, or population.

Valuation

Population

Condition

Viewing 11 - 20 of 44 results

Title	Year(s) of data collection	Valuation Method	Country	Condition
Selection of oncology health state utilities (Clavo B et al., Int J Environ Res Public Health. 2023. doi:10.3390/ijerph20021479)	2019 - 2022	EQ-5D-5L	Spain	Symptomatic Cancer Survivor
DOI 10.7910/DVN/L4V2LU Author(s) Registry, Utilities Description Health state utilities for oncology conditions Sample Characteristics 26 patients with persistent or refractory side effects of cancer treatments to investigate the effects of ozone treatment
Title Selection of oncology health state utilities (Cooper OAE et al., Pharmacoecon Open. 2023. doi:10.1007/s41669-023-00392-4)	Year(s) of data collection 2021	Valuation Method EQ-5D-5L	Country United Kingdom of Great Britain and Northern Ireland	Condition Invasive bladder cancer
DOI 10.7910/DVN/L4V2LU Author(s) Registry, Utilities Description Health state utilities for oncology conditions Sample Characteristics 202 individuals from UK general public
Title Selection of oncology health state utilities (Yang M et al., Value Health. 2023. doi:10.1016/j.jval.2023.02.00)	Year(s) of data collection 2016 - 2021	Valuation Method EQ-5D-5L	Country Austria, Belgium, China, France, Germany, Israel, Italy, Japan, Korea (Republic of), Netherlands, Poland, Spain, Switzerland, Taiwan (Province of China), United States of America	Condition Lung cancer
DOI 10.7910/DVN/L4V2LU Author(s) Registry, Utilities Description Health state utilities for oncology conditions Sample Characteristics 273 patients with non-small cell lung cancer harboring MET exon 14 skipping treated with tepotinib
Title Selection of neurological disease health state utilities (Kalra S et al., Cureus. 2023. doi:10.7759/cureus.35045)	Year(s) of data collection 2017 - 2020	Valuation Method EQ-5D-3L	Country India	Condition Epilepsy
DOI 10.7910/DVN/VJSSSX Author(s) Registry, Utilities Description Health state utilities for neurological disease conditions Sample Characteristics 173 participants in a cohort study from a community-based randomized controlled trial to compare the QOL between people with epilepsy receiving home-based care (HBC) and routine clinic-based care (CBC)
Title Selection of neurological disease health state utilities (Janssen N et al., J Alzheimers Dis. 2022. doi:10.3233/JAD-215304)	Year(s) of data collection 2009 - 2011	Valuation Method SF-6D	Country Finland	Condition Cognitive decline
DOI 10.7910/DVN/VJSSSX Author(s) Registry, Utilities Description Health state utilities for neurological disease conditions Sample Characteristics 1120 participants with longitudinal 2-year data from the FINGER study to investigate the association between cognition, health related quality of life, and costs in a population at risk for cognitive decline
Title Selection of neurological disease health state utilities (Gebrehiwet P et al., J Med Econ. 2023. doi:10.1080/13696998.2023.2192588)	Year(s) of data collection 2017 - 2019	Valuation Method EQ-5D-5L	Country Australia, Canada, Ireland, Netherlands, Spain, United States of America	Condition Amyotrophic lateral sclerosis
DOI 10.7910/DVN/VJSSSX Author(s) Registry, Utilities Description Health state utilities for neurological disease conditions Sample Characteristics 456 participants with clinical trial data from FORTITUDE-ALS that evaluated reldesemtiv versus placebo in patients with ALS
Title Selection of neurological disease health state utilities (Looby A et al., J Med Econ. 2023. doi:10.1080/13696998.2023.2189395)	Year(s) of data collection 2022	Valuation Method EQ-5D-5L	Country United Kingdom of Great Britain and Northern Ireland	Condition Spinal cord injury
DOI 10.7910/DVN/VJSSSX Author(s) Registry, Utilities Description Health state utilities for neurological disease conditions Sample Characteristics A cohort of 57 patients with spinal cord injury
Title Selection of neurological disease health state utilities (Lacy B et al., Clin Park Relat Disord. 2023. doi:10.1016/j.prdoa.2022.100180)	Year(s) of data collection 2010 - 2011	Valuation Method EQ-5D	Country United States of America	Condition Parkinson's disease
DOI 10.7910/DVN/VJSSSX Author(s) Registry, Utilities Description Health state utilities for neurological disease conditions Sample Characteristics A cross-sectional study of 124 patients with PD at an academic movement clinic
Title Selection of mental health health state utilities (Shoji M et al., BMC Psychiatry. 2023. doi:10.1186/s12888-023-04602-5)	Year(s) of data collection 2019 - 2020	Valuation Method EQ-5D-5L	Country Japan	Condition Depression
DOI 10.7910/DVN/QNA5ZF Author(s) Registry, Utilities Description Health state utilities for mental health conditions Sample Characteristics 31 participants in a non-randomized controlled, interventional study investigating effects of community pharmacists' cognitive behavioral therapy based interventions on medication adherence and relevant indicators in patients with depression
Title Selection of mental health health state utilities (Adu MK et al., Brain Sci. 2023. doi:10.3390/brainsci13020293)	Year(s) of data collection 2020 - 2022	Valuation Method EQ-5D-5L	Country Canada	Condition Depression
DOI 10.7910/DVN/QNA5ZF Author(s) Registry, Utilities Description Health state utilities for mental health conditions Sample Characteristics 78 participants in the patient-centered randomized controlled pilot trial investigating combining repetitive transcranial magnetic stimulation with internet-delivered cognitive behavior therapy for the treatment of resistant depression

← Previous results Next results →